Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPI-1019 in Mild-Moderate Alzheimer's Disease
NCT00100334Phase 2Completed
- Sponsor
- Praecis Pharmaceuticals Incorporated
- Start
- Dec 2004
- Countries
- 1
01
Overview
A Phase 2 trial of PPI-1019 in Alzheimer's disease (AD), sponsored by Praecis Pharmaceuticals Incorporated. Started Dec 2004; status: completed.
02
Drugs
PPI-1019
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00100334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100334.